2017
DOI: 10.2147/nds.s144761
|View full text |Cite
|
Sign up to set email alerts
|

Effects of <em>p</em>-synephrine in combination with caffeine: a review

Abstract: Abstract:This review summarizes the current research involving p-synephrine in combination with caffeine. Over 30 clinical human studies with in excess of 700 subjects, and animal and in vitro studies have assessed the safety, efficacy, and mechanism of action of Citrus aurantium (bitter orange) extract and its primary active constituent p-synephrine. Approximately 35% of these human subjects concurrently consumed caffeine, a stimulant thermogenic agent. In these clinical investigations, no serious adverse eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 51 publications
0
6
0
Order By: Relevance
“…Bitter orange extract and its primary protoalkaloid p ‐synephrine have come under recent scrutiny by the Food and Drug Administration, with references made to its potential “stimulant” and cardiovascular effects. p‐ Synephrine is frequently combined with caffeine, a well‐known stimulant (Stohs & Ratamess, ). Common indicators of central nervous system (CNS) stimulatory activity are increases in heart rate (HR), and diastolic (DBP) and systolic blood pressure (SBP).…”
Section: Introductionmentioning
confidence: 99%
“…Bitter orange extract and its primary protoalkaloid p ‐synephrine have come under recent scrutiny by the Food and Drug Administration, with references made to its potential “stimulant” and cardiovascular effects. p‐ Synephrine is frequently combined with caffeine, a well‐known stimulant (Stohs & Ratamess, ). Common indicators of central nervous system (CNS) stimulatory activity are increases in heart rate (HR), and diastolic (DBP) and systolic blood pressure (SBP).…”
Section: Introductionmentioning
confidence: 99%
“…The bioactive alkaloid within WDT is synephrine [ 2 , 30 ], which is a phenylethylamine derivative [ 56 ], also found in bitter orange ( Citrus aurantium L. from the Rutaceae family) [ 57 ]. There are three isomeric forms of synephrine: m-synephrine, p-synephrine, and o-synephrine.…”
Section: Discussionmentioning
confidence: 99%
“…Since ephedra and its preparations were prohibited for use in FS [44], the use of the alternative compound p-synephrine is rising. This phenylethylamine derivative with sympathomimetic action is present in weight loss and sports performance enhancement supplements prepared from bitter orange (Citrus aurantium) [165]. However, consumption of high amounts of synephrine also presents adverse cardiovascular effects concerns, especially in the common association with caffeine [166].…”
Section: Pharmacologically Active Ingredientsmentioning
confidence: 99%